Download presentation
Presentation is loading. Please wait.
Published byAndra Prudence McKenzie Modified over 5 years ago
1
The outcome of the initial assessment of hepatocellular carcinoma (HCC) by a multidisciplinary meeting (MDM) with respect to treatment categorised as resection, liver transplantation, locoregional (L-R) therapies and biological agents or palliation. The outcome of the initial assessment of hepatocellular carcinoma (HCC) by a multidisciplinary meeting (MDM) with respect to treatment categorised as resection, liver transplantation, locoregional (L-R) therapies and biological agents or palliation. John G O'Grady Frontline Gastroenterol 2013;4: Copyright © BMJ Publishing Group Ltd & British Society of Gastroenterology. All rights reserved.
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.